Drug profile · INN
divalproex sodium
DIVALPROEX SODIUM
divalproex sodium (DIVALPROEX SODIUM) is a succinate semialdehyde dehydrogenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — divalproex sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 4
- Data quality
- 0.89
Quick answer
divalproex sodium (DIVALPROEX SODIUM) is a succinate semialdehyde dehydrogenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Succinate semialdehyde dehydrogenase inhibitor
Primary target: Succinate-semialdehyde dehydrogenase, mitochondrial
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is divalproex sodium?
divalproex sodium (DIVALPROEX SODIUM) is a succinate semialdehyde dehydrogenase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for divalproex sodium?
DIVALPROEX SODIUM is a marketed brand name for divalproex sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of divalproex sodium?
divalproex sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.